Microba Life Sciences
(ASX) MAP
Microba Life Sciences Financials at a Glance
Market Cap
$45.67M
Revenue (TTM)
$31.81M
Net Income (TTM)
$33.95M
EPS (TTM)
$-0.04
P/E Ratio
-1.95
Dividend
$0.00
Beta (Volatility)
-0.14 (Low)
Dividend
$0.00
Beta (Volatility)
-0.14 (Low)
Price
$0.07
Volume
20,000
Open
$0.07
Price
$0.07
Volume
20,000
Open
$0.07
Previous Close
$0.07
Daily Range
$0.07 - $0.07
52-Week Range
$0.07 - $0.23
Dividend
$0.00
Beta (Volatility)
-0.14 (Low)
Price
$0.07
Volume
20,000
Open
$0.07
Previous Close
$0.07
Daily Range
$0.07 - $0.07
52-Week Range
$0.07 - $0.23
MAP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Microba Life Sciences
Industry
Healthcare Providers and Services
Sector
Health CareCEO
Luke Reid, PhD
Website
www.microba.comHeadquarters
Brisbane, QLD 4000, AU
MAP Financials
Key Financial Metrics (TTM)
Gross Margin
-20%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
-60%
Return on Capital
-63%
Return on Assets
-46%
Earnings Yield
-51.28%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$45.67M
Shares Outstanding
608.96M
Volume
20.00K
Short Interest
0.00%
Avg. Volume
197.33K
Financials (TTM)
Gross Profit
$7.44M
Operating Income
$24.61M
EBITDA
$10.51M
Operating Cash Flow
$12.01M
Capital Expenditure
$2.90M
Free Cash Flow
$14.91M
Cash & ST Invst.
$11.74M
Total Debt
$3.23M
Microba Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.32M
+123.7%
Gross Profit
$6.58M
-49.3%
Gross Margin
-89.85%
N/A
Market Cap
$45.67M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$10.56M
+8.1%
EBITDA
$8.70M
+16.7%
Quarterly Fundamentals
Net Cash
$7.96M
-70.2%
Accounts Receivable
$2.14M
-81.0%
Inventory
$2.06M
+0.1%
Long Term Debt
$1.79M
+249.7%
Short Term Debt
$1.53M
+75.8%
Return on Assets
-45.56%
N/A
Return on Invested Capital
-63.24%
N/A
Free Cash Flow
$5.89M
+55.7%
Operating Cash Flow
$5.70M
+50.7%